Survival Prolongation by Rationale Innovative Genomics

Clinical trial NCT03386929 · TERMINATED

Trial details

NCT number: NCT03386929
Sponsor: Worldwide Innovative Network Association
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer Metastatic Non-small Cell Lung Cancer Stage IIIB

Start date: 2017-11-29
Primary completion: 2022-12-29
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.